retatrutide approval is one of the most exciting medications currently being studied for obesity and metabolic disease-but there's one important thing to understand: It is NOT approved yet. I get asked almost daily, “ Retatrutide vs. Tirzepatide: The New

Systematic rotation of injection sites is a fundamental practice for patients using injectable medications, essential for preventing complications and maintaining optimal therapeutic outcomes

Retatrutide indirectly improves sleep for many women through several mechanisms

Always discard visibly discolored or cloudy medication and report any unusual symptoms to your healthcare provider immediately

Medicare GLP-1 Bridge Program, Insurance, and How Omzo Fits In Starting July 1, 2026, eligible Medicare beneficiaries can get select FDA-approved GLP-1 medications - Wegovy, Foundayo, and Zepbound KwikPen - for $50 per month through the CMS Medicare GLP-1 Bridge Program

Why Menopausal Women Might Consider GLP-1s for Weight Loss Among the unwelcome symptoms of perimenopause (the hormonally turbulent years before periods stop) and menopause, one rises to the top for many women: weight gain

The most notable usage was in women aged 50-64, among whom 20 percent reported having used a GLP-1RA at least once